Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct OPA1 mutations and clinical pathologies

• Katherine A. Pohl,
• Katherine A. Pohl,
• Xiangmei Zhang,
• Anh H. Pham,
• Jane W. Chan,
• Alfredo A. Sadun,
• Xian-Jie Yang,
• Xian-Jie Yang

Affiliations

Katherine A. Pohl

Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA, United States

Katherine A. Pohl

Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, United States

Xiangmei Zhang

Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA, United States

Anh H. Pham

Department of Ophthalmology, Doheny Eye Institute, University of California, Los Angeles, Pasadena, CA, United States

Jane W. Chan

Department of Ophthalmology, Doheny Eye Institute, University of California, Los Angeles, Pasadena, CA, United States

Alfredo A. Sadun

Department of Ophthalmology, Doheny Eye Institute, University of California, Los Angeles, Pasadena, CA, United States

Xian-Jie Yang

Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA, United States

Xian-Jie Yang

Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, United States